Mice deficient in the mitochondrial branched-chain aminotransferase (BCATm) respond with delayed tumour growth to a challenge with EL-4 lymphoma

BACKGROUND: The mitochondrial branched-chain aminotransferase (BCATm) is a recently discovered cancer marker with a poorly defined role in tumour progression. METHODS: To understand how a loss of function of BCATm affects cancer, the global knockout mouse BCATmKO was challenged with EL-4 lymphoma un...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Br J Cancer
Päätekijät: Ananieva, Elitsa A., Bostic, Joshua N., Torres, Ashley A., Glanz, Hannah R., McNitt, Sean M., Brenner, Michelle K., Boyer, Michael P., Addington, Adele K., Hutson, Susan M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6203766/
https://ncbi.nlm.nih.gov/pubmed/30318512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0283-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia